|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/clinical-trials-in-rare-diseases/
课程评论：没有评论
课程名称：罕见疾病临床试验 概述：本课程旨在解决在进行罕见疾病临床试验时面临的独特挑战。这些疾病虽然只影响少数人口，但对全球产生了重大影响。参与者将学习如何应对这些复杂性，并制定策略以克服罕见疾病研究中的障碍。课程开始时将探讨罕见疾病的定义和流行病学，包括全球用于定义这些疾病的标准及其流行程度。同时，还将讨论患者注册系统（如Orphanet）在提供研究数据方面的重要性。 参与者将面对临床试验设计和患者招募中的挑战。由于患者数量少且地理分散，罕见疾病试验需要创新的策略，以确保稳健的试验设计和足够的患者招募和留存。课程强调适合罕见疾病的创新试验设计，如单臂试验、自适应设计和N-of-1试验，这些设计提供了灵活性和个性化，以克服传统试验结构的局限。 一个重点是与患者协会的合作，强调患者倡导团体在招募、参与和将患者观点纳入研究中的重要性。同时，也将覆盖有效的合作策略。 最后，参与者将全面了解 governing rare disease trials 的监管和伦理指南，如《孤儿药法》等，并学习如何在确保参与者得到伦理对待的同时，合理导航监管环境以加快试验批准过程。本课程非常适合参与罕见疾病试验的临床研究人员、医疗专业人员和监管专家。
This course is designed to address the unique challenges faced when conducting clinical trials for rare diseases, which affect a small percentage of the population but have a significant impact worldwide. Participants will learn how to navigate these complexities and develop strategies to overcome the barriers in rare disease research.The course begins with an exploration of the definition and epidemiology of rare diseases, including criteria used globally to define these conditions and their prevalence. The importance of patient registries, such as Orphanet, in providing data for research will be discussed.Participants will then tackle the challenges in clinical trial design and patient recruitment. Due to small patient populations and geographical dispersion, rare disease trials require innovative strategies to ensure robust trial designs and adequate patient recruitment and retention.The course emphasizes the use of innovative trial designs that are particularly suited for rare diseases, such as single-arm trials, adaptive designs, and N-of-1 trials, which offer flexibility and personalization to overcome the limitations of traditional trial structures.A key focus is on collaboration with patient associations, highlighting the importance of patient advocacy groups in recruitment, engagement, and incorporating patient perspectives into research. Effective partnership strategies will also be covered.Lastly, participants will gain a comprehensive understanding of regulatory and ethical guidelines governing rare disease trials, such as the Orphan Drug Act, and will learn to navigate the regulatory landscape to expedite trial approvals while ensuring ethical treatment of participants.This course is ideal for clinical researchers, healthcare professionals, and regulatory specialists involved in rare disease trials.
